Evidence recommending antiviral therapy in hepatitis C.

dx.doi.org/10.1111/liv.12342, [Epub ahead of print]. [3] Hörl WH. Anaemia management and mortality risk in chronic kidney disease. Nat Rev Nephrol 2013;9:291–301. [4] Kunze A, Huwyler J, Camenisch G, Gutmann H. Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters. Biochem Pharmacol 2012;84:1096–1102. [5] Karino Y, Ozeki I… (More)